137 related articles for article (PubMed ID: 38653576)
1. Anticancer mechanisms of β-carbolines.
Mishra S; Gupta A; Jain S; Vaidya A
Chem Biol Drug Des; 2024 Apr; 103(4):e14521. PubMed ID: 38653576
[TBL] [Abstract][Full Text] [Related]
2. β-Carbolines as potential anticancer agents.
Aaghaz S; Sharma K; Jain R; Kamal A
Eur J Med Chem; 2021 Apr; 216():113321. PubMed ID: 33684825
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel 3,9-substituted β-carboline derivatives as anticancer agents.
Chen YF; Lin YC; Chen JP; Chan HC; Hsu MH; Lin HY; Kuo SC; Huang LJ
Bioorg Med Chem Lett; 2015 Sep; 25(18):3873-7. PubMed ID: 26235951
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive overview of β-carbolines and its derivatives as anticancer agents.
Luo B; Song X
Eur J Med Chem; 2021 Nov; 224():113688. PubMed ID: 34332400
[TBL] [Abstract][Full Text] [Related]
5. Recent insights into synthetic β-carbolines with anti-cancer activities.
Kumar S; Singh A; Kumar K; Kumar V
Eur J Med Chem; 2017 Dec; 142():48-73. PubMed ID: 28583770
[TBL] [Abstract][Full Text] [Related]
6. New 3-tetrazolyl-β-carbolines and β-carboline-3-carboxylates with anti-cancer activity.
Panice MR; Lopes SMM; Figueiredo MC; Goes Ruiz ALT; Foglio MA; Nazari Formagio AS; Sarragiotto MH; Pinho E Melo TMVD
Eur J Med Chem; 2019 Oct; 179():123-132. PubMed ID: 31247374
[TBL] [Abstract][Full Text] [Related]
7. Molecular hybrid design, synthesis, in vitro and in vivo anticancer evaluation, and mechanism of action of N-acylhydrazone linked, heterobivalent β-carbolines.
Guo L; Chen X; Chen W; Ma Q; Fan W; Zhang J; Dai B
Bioorg Chem; 2020 Mar; 96():103612. PubMed ID: 32007724
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives.
Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH
Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Structure-Activity Relationships of Tetrahydro-β-carboline Derivatives as Anticancer and Cancer-chemopreventive Agents.
Zhang M; Park EJ; Kondratyuk TP; Pezzuto JM; Sun D
Anticancer Res; 2018 Aug; 38(8):4425-4433. PubMed ID: 30061206
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of some β-carboline derivatives as multi-target anticancer agents.
Abdelsalam MA; AboulWafa OM; Badawey EA; El-Shoukrofy MS; El-Miligy MM; Gouda N
Future Med Chem; 2018 Dec; 10(24):2791-2814. PubMed ID: 30539666
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and 3D-QSAR of beta-carboline derivatives as potent antitumor agents.
Cao R; Guan X; Shi B; Chen Z; Ren Z; Peng W; Song H
Eur J Med Chem; 2010 Jun; 45(6):2503-15. PubMed ID: 20304536
[TBL] [Abstract][Full Text] [Related]
12. A review of synthetic bioactive tetrahydro-β-carbolines: A medicinal chemistry perspective.
Wang J; Gong F; Liang T; Xie Z; Yang Y; Cao C; Gao J; Lu T; Chen X
Eur J Med Chem; 2021 Dec; 225():113815. PubMed ID: 34479038
[TBL] [Abstract][Full Text] [Related]
13. Discovery of β-carboline copper(II) complexes as Mcl-1 inhibitor and in vitro and in vivo activity in cancer models.
Lu X; Liu YC; Orvig C; Liang H; Chen ZF
Eur J Med Chem; 2019 Nov; 181():111567. PubMed ID: 31401535
[TBL] [Abstract][Full Text] [Related]
14. Syntheses of novel β-carboline derivatives and the activities against five tumor-cell lines.
Bai B; Li XY; Liu L; Li Y; Zhu HJ
Bioorg Med Chem Lett; 2014 Jan; 24(1):96-8. PubMed ID: 24345445
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel hybrids β-carboline-4-thiazolidinones as potential antitumor and antiviral agents.
Barbosa VA; Baréa P; Mazia RS; Ueda-Nakamura T; Costa WFD; Foglio MA; Goes Ruiz ALT; Carvalho JE; Vendramini-Costa DB; Nakamura CV; Sarragiotto MH
Eur J Med Chem; 2016 Nov; 124():1093-1104. PubMed ID: 27792980
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro cytotoxic evaluation of novel 3,4,5-trimethoxyphenyl substituted beta-carboline derivatives.
Wu Q; Cao R; Feng M; Guan X; Ma C; Liu J; Song H; Peng W
Eur J Med Chem; 2009 Feb; 44(2):533-40. PubMed ID: 18462839
[TBL] [Abstract][Full Text] [Related]
17. The preparation and evaluation of 1-substituted 1,2,3,4-tetrahydro- and 3,4-dihydro-beta-carboline derivatives as potential antitumor agents.
Shen YC; Chen CY; Hsieh PW; Duh CY; Lin YM; Ko CL
Chem Pharm Bull (Tokyo); 2005 Jan; 53(1):32-6. PubMed ID: 15635225
[TBL] [Abstract][Full Text] [Related]
18. Discovery of tetrahydro-beta-carbolines as inhibitors of the mitotic kinesin KSP.
Liu F; Yu LQ; Jiang C; Yang L; Wu WT; You QD
Bioorg Med Chem; 2010 Jun; 18(12):4167-77. PubMed ID: 20537544
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances of Natural and Synthetic β-Carbolines as Anticancer Agents.
Zhang M; Sun D
Anticancer Agents Med Chem; 2015; 15(5):537-47. PubMed ID: 25430895
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, anticancer screening, docking studies and in silico ADME prediction of some β-carboline derivatives.
Abdelsalam MA; AboulWafa OM; M Badawey EA; El-Shoukrofy MS; El-Miligy MM; Gouda N; Elaasser MM
Future Med Chem; 2018 May; 10(10):1159-1175. PubMed ID: 29787297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
